Foamix Pharmaceuticals Ltd. Conversion of Stock, Amount Converted
Foamix Pharmaceuticals Ltd. reported Conversion of Stock, Amount Converted of $13.44 million for the 12-month period ending 2014-12-31, per its 20-F filed 2017-02-21.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockAmountConverted1 · last filed 2017-02-21
| Period end | Conversion of Stock, Amount Converted 6 month | Conversion of Stock, Amount Converted 12 month |
|---|---|---|
| 2014-12-31 | $13.44M 20-F · filed 2017-02-21 | |
| 2014-06-30 | $8.07M 6-K · filed 2015-10-19 |